Tackling Solid Tumor Heterogeneity Through Polyclonal Killers

Thank you to our speakers, sponsors, and delegates who joined us in Boston for the summit! If you are interested in the 2026 event, please get in touch at info@hansonwade.com.

Translating Optimized TIL Selection, Engineering, & Manufacturing into Potent Scalable Solid Tumor Treatments Beyond Melanoma

One year on from the first approved TIL Therapy in the US, and with Canada and EMA expected to make approval decisions in the coming months, this is a pivotal time for drug developers looking to address treatment-resistant solid tumors.

Returning for its 7th year, the TIL Therapies Summit remained the go-to forum for this close-knit community, created with the mission to transform end-to-end TIL development and deliver best-in-class therapies to treat solid tumor indications with significant unmet needs.

With more patients being treated than ever, this summit united a global collective of biopharma, academic thought leaders, clinicians, and patients as they shared their cutting-edge research into engineered TIL, easier manufacturing, and lived experiences with TIL Therapies.

Active discussion on current issues in TIL research and regulatory matters, friendly environment for participating in the discussion, meeting TIL leaders, and sharing ideas on TIL research. The summit shared updates on brand-new data on TIL research and updated information.

Research Fellow, NeogenTC, 2024 Attendee 

NeogenTC

The talks were all very interesting, and getting to hear first-hand from long-time TIL researchers and experts in a small setting was invaluable.

Senior Director - Scientific & Strategic Communications, Obsidian Therapeutics, 2024 Attendee 

Obsidian Therapeutics Logo - Company Attending the 7th TIL Therapies Summit

View the 2025 Full Event Guide to:

  • Meet the 30+ Expert Speakers
  • View Full Session Details
  • Explore Partnership Opportunities
Cover of 7th TIL Therapies Summit Program

2025 Event in Numbers

80+

Attendees

30+

World-Class Speakers

8

Hours of In-Person Networking

2

New R&D and CMC Tracks

3

Conference Days

Meet the 2025 Partners

Cover of 7th TIL Therapies Summit Program
Quick Download

Attending Companies Included

KSQ Therapeutics Logo - Company Attending the 7th TIL Therapies Summit
Obsidian Therapeutics Logo - Company Attending the 7th TIL Therapies Summit
CuraCell Logo - Company Attending the 7th TIL Therapies Summit
Iovance Therapeutics Logo - Company Attending the 7th TIL Therapies Summit
MD Anderson Cancer Center Logo - Company Attending the 7th TIL Therapies Summit
Netherland Cancer Institute Logo - Company Attending the 7th TIL Therapies Summit
Grit Biotechnology Logo - Company Attending the 7th TIL Therapies Summit
Memorial Sloan Kettering Cancer Center Logo - Company Attending the 7th TIL Therapies Summit
Neogap Logo - Company Attending the 7th TIL Therapies Summit
Hanson Wade Event Image

Explore the 2025 Program

Hear the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.

Hanson Wade Event Image

Partner With Us

Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.

Hanson Wade Event Image

Join Biopharma Experts

Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.